Literature DB >> 19338044

Clinical efficacy of WT1 peptide vaccination in patients with acute myelogenous leukemia and myelodysplastic syndrome.

Masaki Yasukawa, Hiroshi Fujiwara, Toshiki Ochi, Koichiro Suemori, Hiroshi Narumi, Taichi Azuma, Kiyotaka Kuzushima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19338044     DOI： 10.1002/ajh.21387

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  8 in total

Review 1.  Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials.

Authors:  Ann Van Driessche; Zwi N Berneman; Viggo F I Van Tendeloo
Journal:  Oncologist       Date:  2012-01-30

2.  WT1 peptide vaccination in a CML patient: induction of effective cytotoxic T lymphocytes and significance of peptide administration interval.

Authors:  Anri Saitoh; Miwako Narita; Norihiro Watanabe; Nozomi Tochiki; Akie Yamahira; Takeshi Nakamura; Masami Kaji; Masayoshi Masuko; Tatsuo Furukawa; Ken Toba; Ichiro Fuse; Yoshifusa Aizawa; Masuhiro Takahashi
Journal:  Med Oncol       Date:  2010-01-27       Impact factor: 3.064

Review 3.  Life after transplant: are we becoming high maintenance in AML?

Authors:  A M Brunner; A T Fathi; Y B Chen
Journal:  Bone Marrow Transplant       Date:  2016-06-20       Impact factor: 5.483

4.  A Novel DNA Vaccine Platform Enhances Neo-antigen-like T Cell Responses against WT1 to Break Tolerance and Induce Anti-tumor Immunity.

Authors:  Jewell N Walters; Bernadette Ferraro; Elizabeth K Duperret; Kimberly A Kraynyak; Jaemi Chu; Ashley Saint-Fleur; Jian Yan; Hy Levitsky; Amir S Khan; Niranjan Y Sardesai; David B Weiner
Journal:  Mol Ther       Date:  2017-02-22       Impact factor: 11.454

5.  First-in-human study of WT1 recombinant protein vaccination in elderly patients with AML in remission: a single-center experience.

Authors:  Stefanie Kreutmair; Dietmar Pfeifer; Miguel Waterhouse; Ferenc Takács; Linda Graessel; Konstanze Döhner; Justus Duyster; Anna Lena Illert; Anna-Verena Frey; Michael Schmitt; Michael Lübbert
Journal:  Cancer Immunol Immunother       Date:  2022-04-27       Impact factor: 6.630

Review 6.  Application of adoptive T-cell therapy using tumor antigen-specific T-cell receptor gene transfer for the treatment of human leukemia.

Authors:  Toshiki Ochi; Hiroshi Fujiwara; Masaki Yasukawa
Journal:  J Biomed Biotechnol       Date:  2010-05-05

7.  Dendritic cell cancer vaccines: from the bench to the bedside.

Authors:  Tamar Katz; Irit Avivi; Noam Benyamini; Jacalyn Rosenblatt; David Avigan
Journal:  Rambam Maimonides Med J       Date:  2014-10-29

Review 8.  Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies.

Authors:  Antonio Di Stasi; Antonio M Jimenez; Kentaro Minagawa; Mustafa Al-Obaidi; Katayoun Rezvani
Journal:  Front Immunol       Date:  2015-02-04       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.